Veterinary Medicines

Metabolase, süstelahus hobustele, veistele, sigadele, lammastele, kitsedele, küülikutele, koertele ja kassidele

Authorised
  • SORBITOL (E420)
  • FRUCTOSE PH.EUR.
  • Glutamic acid
  • Aspartic acid
  • Taurine
  • Glycine
  • L-lysine hydrochloride
  • Citrulline
  • L-ORNITHINE HYDROCHLORIDE
  • L-ARGININE
  • Acetylmethionine
  • Cyanocobalamin
  • Pyridoxine hydrochloride
  • Thioctic acid
  • Levocarnitine hydrochloride
Download as PDF

Product identification

Medicine name:
Metabolase, süstelahus hobustele, veistele, sigadele, lammastele, kitsedele, küülikutele, koertele ja kassidele
Active substance:
  • SORBITOL (E420)
  • FRUCTOSE PH.EUR.
  • Glutamic acid
  • Aspartic acid
  • Taurine
  • Glycine
  • L-lysine hydrochloride
  • Citrulline
  • L-ORNITHINE HYDROCHLORIDE
  • L-ARGININE
  • Acetylmethionine
  • Cyanocobalamin
  • Pyridoxine hydrochloride
  • Thioctic acid
  • Levocarnitine hydrochloride
Target species:
  • Cattle
  • Horse
  • Pig
  • Sheep
  • Goat
  • Dog
  • Cat
  • Rabbit
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intraperitoneal use

Product details

Active substance and strength:
  • SORBITOL (E420)
    80.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • FRUCTOSE PH.EUR.
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Glutamic acid
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Aspartic acid
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Taurine
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • Glycine
    1.50
    milligram(s)
    /
    1.00
    millilitre(s)
  • L-lysine hydrochloride
    0.63
    milligram(s)
    /
    1.00
    millilitre(s)
  • Citrulline
    1.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • L-ORNITHINE HYDROCHLORIDE
    1.53
    milligram(s)
    /
    1.00
    millilitre(s)
  • L-ARGININE
    2.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Acetylmethionine
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Cyanocobalamin
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyridoxine hydrochloride
    0.15
    milligram(s)
    /
    1.00
    millilitre(s)
  • Thioctic acid
    0.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • Levocarnitine hydrochloride
    6.13
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
  • Intraperitoneal use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BA10
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1128
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 19/10/2024
Updated on: 18/10/2024
Download